JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera

Leukemia and Lymphoma

Volumn 49, Issue 3, 2008, Pages 586-588

  Röthlisberger, Benno ^a   Huber, Andreas ^a   Bargetzi, Mario ^b   Mendez, Adriana ^a   Heizmann, Marc ^b  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b Center of Oncology/Hematology and Transfusion Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; JANUS KINASE 2;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; DNA SEQUENCE; EXON; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE DELETION; GENETIC SCREENING; HUMAN; HUMAN CELL; MALE; MUTATIONAL ANALYSIS; ONSET AGE; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA;

EID: 39749116146     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701861652     Document Type: Article

References (10)

1. Levine, R. L., Pardanani, A., Tefferi, A. and Gilliland, D. G. (2007) Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer, 7, pp. 673-683.
2. Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A. and Stratton, M. R. (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med, 356, pp. 459-468.
3. Pardanani, A., Lasho, T. L., Finke, C., Hanson, C. A. and Tefferi, A. (2007) Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia, 21, pp. 1960-1963.
4. Scott, L. M., Beer, P. A., Bench, A. J., Erber, W. N. and Green, A. R. (2007) Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera. Br J Haematol, 139, pp. 511-512.
5. Butcher, C. M., Hahn, U., To, L. B., Gecz, J., Wilkins, E. J. and Scott, H. S. (2007) Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia
6. Colaizzo, D., Amitrano, L., Tiscia, G. L., Grandone, E., Guardascione, M. A. and Margaglione, M. (2007) A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood, 110, p. 2768.
7. Williams, D. M., Kim, A. H., Rogers, O., Spivak, J. L. and Moliterno, A. R. (2007) Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Exp Hematol, 35, pp. 1641-1646.
8. Pietra, D., Li, S., Brisci, A., Passamonti, F., Rumi, E. and Theocharides, A. (2007) Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood
9. Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H. M., Barbui, T. and Hanson, C. A. (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood, 110, pp. 1092-1097.
10. Jones, A. V., Kreil, S., Zoi, K., Waghorn, K., Curtis, C. and Zhang, L. (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 106, pp. 2162-2168.